SEC Form 4 · accession 0001144204-15-045629
BRAINSTORM CELL THERAPEUTICS INC. · BCLI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Yoram Bibring
Officer — Chief Financial Officer
Period of report
Jul 30, 2015
Accepted (ET)
Aug 3, 2015 · 10:14 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001137883
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $3.17 | Jul 30, 2015 | A | 165,000 | A | Jul 30, 2015 | Jul 30, 2025 | Common Stock | 165,000 | 165,000 | D |
Explanation of responses
- F1Option vests as to 25% of the number of shares on the first anniversary of the grant date and then monthly thereafter until fully vested on the fourth anniversary of the grant date.